KATEY HALL: Open Payments
NPI 1437785508 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$323 in 16 payments from 7 companies in 2025. Trend: 2023 $83 · 2024 $110 · 2025 $323
Food & beverage: $323
| Company | Payments | Amount |
|---|---|---|
| Pulmonx Corporation | 4 | $72 |
| Ambu Inc. | 2 | $68 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| ABBVIE INC. | 3 | $51 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| Becton, Dickinson and Company | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: CHARTIS CATHETER, TRELEGY ELLIPTA, ZERBAXA, EMBLAVEO, TEFLARO, GLASSIA.
Industry payments across MS — which companies pay providers there.
